William White
2021
In 2021, William White earned a total compensation of $1.8M as Chief Financial Officer at Akero Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $169,507 |
|---|---|
| Option Awards | $1,190,645 |
| Salary | $423,766 |
| Total | $1,783,918 |
White received $1.2M in option awards, accounting for 67% of the total pay in 2021.
White also received $169.5K in non-equity incentive plan and $423.8K in salary.
Rankings
In 2021, William White's compensation ranked 6,498th out of 12,415 executives tracked by ExecPay. In other words, White earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,498 out of 12,415 | 48th |
Division Manufacturing | 2,787 out of 5,508 | 49th |
Major group Chemicals And Allied Products | 1,230 out of 2,378 | 48th |
Industry group Drugs | 1,097 out of 2,099 | 48th |
Industry Pharmaceutical Preparations | 796 out of 1,549 | 49th |
Source: SEC filing on April 28, 2023.
White's colleagues
We found four more compensation records of executives who worked with William White at Akero Therapeutics in 2021.